Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Moore David Scott | Dir | P Purchase | — | $11.53 | $250K | filing |
CORVUS PHARMACEUTICA (CRVS) insider trading activity (SEC Form 4). Over the trailing 90 days, CRVS insiders filed 1 purchases totalling $250K and 0 sales totalling $0 — net BUYING of $250K. Most recent filing: Jun 15, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Moore David Scott | Dir | P Purchase | — | $11.53 | $250K | filing |